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Abstract—We tested the hypothesis that activation of transient receptor potential vanilloid type-1 (TRPV1) by capsaicin
prevents adipogenesis. TRPV1 channels in 3T3-L1-preadipocytes and visceral adipose tissue from mice and humans
were detected by immunoblotting and quantitative real-time RT-PCR. The effect of TRPV1 on cytosolic calcium was
determined fluorometrically in 3T3-L1-preadipocytes and in human visceral fat tissue. Adipogenesis in stimulated
3T3-L1-preadipocytes was determined by oil red O-staining of intracellular lipid droplets, triglyceride levels, expression
of peroxisome proliferator-activated receptor-, and expression of fatty acid synthase. Long-term feeding experiments
were undertaken in wild-type mice and TRPV1 knockout mice.
We detected TRPV1 channels in 3T3-L1-preadipocytes and visceral adipose tissue from mice and humans. In vitro, the TRPV1
agonist capsaicin dose-dependently induced calcium influx and prevented the adipogenesis in stimulated 3T3-L1-
preadipocytes. RNA interference knockdown of TRPV1 in 3T3-L1-preadipocytes attenuated capsaicin-induced calcium
influx, and adipogenesis in stimulated 3T3-L1-preadipocytes was no longer prevented. During regular adipogenesis TRPV1
channels were downregulated which was accompanied by a significant and time-dependent reduction of calcium influx.
Compared with lean counterparts in visceral adipose tissue from obese db/db and ob/ob mice, and from obese human male
subjects we observed a reduced TRVP1 expression. The reduced TRPV1 expression in visceral adipose tissue from obese
humans was accompanied by reduced capsaicin-induced calcium influx. The oral administration of capsaicin for 120 days
prevented obesity in male wild type mice but not in TRPV1 knockout mice assigned to high fat diet. We conclude that the
activation of TRPV1 channels by capsaicin prevented adipogenesis and obesity. (Circ Res. 2007;100:1063-1070.)
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Visceral obesity as clinically assessed by waist circum-ference depends on the proliferation and growth of
preadipocytes which is closely regulated by several genes and
extracellular factors.1–3 Among these factors capsaicin ((E)-
N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-
nonenamide) has been shown to affect lipid metabolism and
obesity.4,5 However, the underlying mechanisms by which
capsaicin affect visceral adipose tissue have not been completely
clarified yet. Recent studies indicated that capsaicin activates the
transient receptor potential vanilloid type-1 (TRPV1) chan-
nel.6–8 The capsaicin receptor TRPV1 belongs to the family of
nonselective cation channels with high calcium permeability.9
Now, we tested the hypothesis that capsaicin-induced
activation of TRPV1 in preadipocytes prevents adipogenesis
and obesity. We showed that the activation of TRPV1
channels by capsaicin increased cytosolic calcium and pre-
vented adipogenesis of preadipocytes in vitro. The effects of
capsaicin on adipogenesis were attenuated after TRPV1
knockdown. Furthermore, capsaicin prevented TRPV1 down-
regulation during adipogenesis. Finally the administration of
capsaicin prevented obesity in male wild-type mice but not in
TRPV1 knockout mice assigned to high fat diet in vivo.
Materials and Methods
Detailed methods, sequences, and reagents used can be found in the
online data supplement available at http://circres.ahajournals.org.
Culture of murine 3T3-L1 preadipocytes,10–15 RNA interference
technique,16 measurements of cytosolic calcium,17,18 immunoblottings,
immunohistochemistry, determination of adipocyte size, PCR, and
standardized techniques17–19 were performed as described previously.
All mice (db/db mice, ob/ob mice, C57BL/6 wild-type mice, and
TRPV1 knock-out mice) were purchased from the Jackson Labora-
tory (Bar Harbor, Maine). Procedures were performed in accordance
with protocols approved by the Institutional Animal Care and
Research Advisory Committee.
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Subjects were classified obese if waist circumference was 90
cm.20,21 The protocol was approved by the local Ethics Committee.
All patients gave written informed consent.
All values reported are meanSEM. Comparisons between groups
were analyzed using Student t test or one-way ANOVA with Bonfer-
roni’s multiple comparison post hoc test as appropriate (GraphPad
Prism, La Jolla, Calif). Two-sided probability values 0.05 were
considered to indicate statistical significance.
Results
First, we detected TRPV1 in 3T3-L1-preadipocytes and vis-
ceral adipose tissue from mice and humans by immunoblot-
ting (Figure 1a) and immunohistochemistry (Figure 1b). The
immunoblots confirmed the molecular mass of TRPV1 of 95
kDa and showed that the antibodies identified TRPV1 in both
3T3-L1-preadipocytes and visceral adipose tissue. Immuno-
histochemistry demonstrated specific staining for TRPV1 in
the cell membrane of 3T3-L1-preadipocytes and adipocytes
from mice and humans.
Caterina et al6 and Savidge et al22 showed that the specific
agonist capsaicin induces calcium influx through TRPV1
channels. To confirm the functional properties of TRPV1
channels in 3T3-L1-preadipocytes intracellular calcium con-
centrations were measured using the fluorescent dye tech-
nique. We used 3T3-L1-preadipocytes because they are an
established model for characterizing the events responsible
for adipocyte differentiation.10,12 As shown in Figure 1c, the
TRPV1 agonist capsaicin dose-dependently increased intra-
cellular calcium in fura-2 loaded 3T3-L1-preadipocytes. The
capsaicin-induced calcium increase could be observed at a
concentration of 10 nmol/L, whereas the maximum effect was
obtained at 1 mol/L.
Based on previous findings by Miller et al10 and Shi et al11
that a calcium increase inhibits differentiation of preadipo-
cytes we now evaluated the effect of capsaicin on adipogen-
esis of 3T3-L1-preadipocytes. Adipogenesis was induced in
3T3-L1-preadipocytes using 3-isobutyl-1-methylxanthine,
dexamethasone, and insulin as recommended.12,13 The differ-
entiation of preadipocytes was examined by four different
functional tests, including oil red O-staining of intracellular
lipid droplets,13 determination of triglyceride levels, expres-
sion of peroxisome proliferator-activated receptor- (PPAR-),
a key transcriptional regulator of adipogenesis,14 and the expres-
sion of fatty acid synthase, a key enzyme in de novo lipogene-
sis.15 Increased oil red O-staining of lipid droplets in cells
indicated a time-dependent adipocyte differentiation after in-
duction of adipogenesis with 3-isobutyl-1-methylxanthine,
dexamethasone, and insulin (Figure 1d). After induction of
adipogenesis cells differentiated into morphologically distinct,
fat-laden adipocytes with accumulated cytoplasmic triglycerides
that stained with oil red O. Under control conditions increased
lipid droplets could be observed approximately 3 days after
induction of adipogenesis. In the presence of the TRPV1 agonist
capsaicin (final concentration, 1mol/L) we observed a reduced
oil red O-staining of cells after the induction of adipogenesis. In
contrast, administration of the TRPV1 antagonist capsazepine
did not prevent adipogenesis in 3T3-L1-preadipocytes.
Determination of cellular triglyceride levels confirmed that
capsaicin prevented adipogenesis. Compared with control
conditions the induction of adipogenesis for 8 days signifi-
cantly increased triglyceride levels from 3.40.2 mmol/L to
10.80.8 mmol/L in 3T3-L1-preadipocytes (each n5;
P0.01). The triglycerides levels after induction of adipo-
genesis for 8 days in the presence of capsaicin were signifi-
cantly lower compared with the values in the absence of
capsaicin (6.20.4 mmol/L versus 10.80.8 mmol/L; each
n5; P0.01). In contrast, administration of the TRPV1
antagonist capsazepine did not prevent the increase of triglycer-
ide levels in 3T3-L1-preadipocytes during adipogenesis
(12.30.6 mmol/L; n5). Compared with control conditions
the induction of adipogenesis for 8 days significantly increased
the expression of PPAR- from 1.000.06 to 2.020.01 in
3T3-L1-preadipocytes (each n5; P0.01). The expression of
PPAR- after induction of adipogenesis for 8 days in the
presence of capsaicin was significantly lower compared with the
values in the absence of capsaicin (1.180.16 versus
2.020.01; each n5; P0.01). In contrast, administration of
the TRPV1 antagonist capsazepine did not prevent the increased
expression of PPAR- in 3T3-L1-preadipocytes during adipo-
genesis (1.750.12; n5). Finally, compared with control
conditions the induction of adipogenesis for 8 days significantly
increased the expression of fatty acid synthase from 1.010.08
to 2.990.09 in 3T3-L1-preadipocytes (each n4; P0.01).
The expression of fatty acid synthase after induction of adipo-
genesis for 8 days in the presence of capsaicin was significantly
lower compared with the values in the absence of capsaicin
(1.170.10 versus 2.990.09; each n4; P0.01). In contrast,
administration of the TRPV1 antagonist capsazepine did not
prevent the increased expression of fatty acid synthase in
3T3-L1-preadipocytes during adipogenesis (2.860.15; n4).
As negative controls we showed that without the induction
of adipogenesis by 3-isobutyl-1-methylxanthine, dexametha-
sone, and insulin neither capsaicin nor capsazepine had a
significant effect on the production of lipid droplets in 3T3-L1-
preadipocytes (Figure 1d). Without induction of adipogenesis
triglyceride levels in 3T3-L1-preadipocytes were similar at day
8 under control conditions (3.40.2mmol/L), in the presence of
capsaicin (3.30.2mmol/L) or capsazepine (3.70.3 mmol/L;
each n5; pn.s.). Without induction of adipogenesis expres-
sion of PPAR- in 3T3-L1-preadipocytes was similar at day 8
under control conditions (1.000.06), in the presence of capsa-
icin (1.230.03) or capsazepine (1.000.04; each n5;
pn.s.). Finally, without induction of adipogenesis expression
of fatty acid synthase in 3T3-L1-preadipocytes was similar at
day 8 under control conditions (1.010.08), in the presence or
capsaicin (1.100.09) or capsazepine (0.990.10; each n4;
pn.s.). From these experiments it is concluded that the
capsaicin-induced calcium increase through TRPV1 channels
prevented adipogenesis.
During adipogenesis of 3T3-L1-preadipocytes induced by
3-isobutyl-1-methylxanthine, dexamethasone, and insulin a
time-dependent downregulation of TRPV1 expression could
be observed by immunoblotting (Figure 1e). The downregu-
lation of TRPV1 expression during adipogenesis was prevented
in the presence of the TRPV1 agonist capsaicin. Eight days after
induction of adipogenesis in 3T3-L1-preadipocytes, TRPV1
channel expression was significantly reduced from control value
of 1.000.08 to 0.460.03 (each n4; P0.01), whereas it was
1.350.03 (n4; P0.01 compared with control) when the
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induction of adipogenesis was performed in the presence of
capsaicin. The administration of the TRPV1 antagonist capsaz-
epine did not prevent the downregulation of TRPV1 channel
after induction of adipogenesis in 3T3-L1-preadipocytes.
The capsaicin-induced calcium increase was significantly
lower in mature adipocytes compared with 3T3-L1-preadipocytes
(324%, versus 10011%; each n10; P0.01; Figure 1f). In
accordance with the observed downregulation of TRPV1 chan-
Figure 1. The TRPV1 channel agonist cap-
saicin increases calcium, prevents adipo-
genesis, and prevents downregulation of
TRPV1 channels in 3T3–L1-preadipocytes.
a, Immunoblot of TRPV1 obtained from
3T3–L1-preadipocytes (3T3–L1), from vis-
ceral adipose tissue (vis fat). The predicted
molecular weight of TRPV1 is 95 kDa. M
denotes marker. Immunoblots are repre-
sentative of 3 separate experiments show-
ing similar results. b, Immunohistochemical
staining of 3T3–L1-preadipocytes (3T3–L1),
visceral adipose tissue (vis fat) from
mouse and from humans with anti-TRPV1
antibody showing TRPV1 on the mem-
brane surface. A negative control (only
second antibody added) is shown in upper
left panel. For 3T3–L1-preadipocytes an
overlay with the nucleus stained using PI
(red color) and TRPV1 stained in green is
shown. Panels are representative of 3 sep-
arate experiments showing similar results.
Bar denotes 10 m. c, Concentration-
dependent increase of cytosolic free cal-
cium concentration in 3T3–L1-
preadipocytes after addition of capsaicin.
Fura2-loaded 3T3–L1-preadipocytes were
stimulated with increasing capsaicin con-
centrations (in nmol/L) as indicated beside
each tracing and the fluorescence was
measured at 510 nm emission with excita-
tion wavelengths of 340 nm and 380 nm.
Data are meanSEM from 6 separate
experiments. d, Capsaicin prevents adipo-
genesis in 3T3–L1-preadipocytes. Identifi-
cation of adipogenesis in 3T3–L1-
preadipocytes in the absence (control) and
presence of TRPV1 agonist capsaicin or
TRPV1 antagonist capsazepine. Lipid
droplets were visualized by oil red
O-staining. Upper panels were obtained
without induction of adipogenesis of 3T3–
L1-preadipocytes (unstimulated), whereas
lower panels were obtained after induction
of adipogenesis of 3T3–L1-preadipocytes
for several days (stimulated) as indicated.
Scale bar indicates 10 m; magnification,
400. Representative pictures of 3 sepa-
rate experiments are shown. e, Capsaicin
prevents the downregulation of TRPV1
expression during adipogenesis of 3T3–
L1-preadipocytes. Adipogenesis was
induced in the absence (control) and pres-
ence of TRPV1 agonist capsaicin or
TRPV1 antagonist capsazepine for 8 days. TRPV1 expression in 3T3–L1-preadipocytes was measured at the indicated days. Data are
meanSEM. **P0.01 compared with control (absence of capsaicin, day 1). f, Reduced capsaicin-induced calcium influx into adipocytes
compared with 3T3–L1-preadipocytes. 3T3–L1-preadipocytes were cultured without induction of adipogenesis (unstimulated) and with induc-
tion of adipogenesis (stimulated) to generate adipocytes for 8 days. Fluorescence tracings after addition of 1 mol/L capsaicin to fura2-
loaded 3T3–L1-preadipocytes or fura2-loaded adipocytes are shown. Data are meanSEM from 6 separate experiments. g, Time-dependent
reduction of capsaicin (1 mol/L)-induced calcium influx during adipogenesis. Calcium influx into 3T3-L1-preadipocytes which were cultured
with induction of adipogenesis in the absence (control) and presence of capsaicin was measured at different time points as indicated. Data
are meanSEM from 6 separate experiments. *P0.05 compared with control (absence of capsaicin, day 3). P0.05 compared with cap-
saicin (day 8). h, RNAi knockdown of TRPV1 reduces capsaicin-induced calcium influx into 3T3-L1-preadipocytes. Fluorescence tracings
after addition of 1mol/L capsaicin to fura2-loaded 3T3-L1-preadipocytes after control transfection (Control) and after transfection with RNAi
against TRPV1 (RNAi). Data are meanSEM from 6 separate experiments. i, Capsaicin did not prevent adipogenesis in TRPV1 knockdown
3T3-L1-preadipocytes. 3T3-L1-preadipocytes after control transfection (3T3-L1) and after transfection with RNAi against TRPV1 (TRPV1-
RNAi-3T3-L1) were stimulated with by 3-isobutyl-1-methylxanthine, dexamethasone, and insulin in the absence (control) and presence of
TRPV1 agonist capsaicin. Scale bar indicates 10 m; magnification, 200. Representative pictures of 3 separate experiments are shown.
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nel expression during adipogenesis, we observed a significant
and time-dependent reduction of calcium influx during adipo-
genesis. On the other hand, the calcium influx was unchanged
when adipogenesis was blocked in the presence of capsaicin
(Figure 1g). Resting cytosolic calcium concentration was not
significantly different in mature adipocytes compared with
3T3-L1-preadipocytes or stimulated 3T3-L1-preadipocytes in
the presence of capsaicin (1042 nmol/L; 1014 nmol/L;
1053 nmol/L; each n12; pn.s.), probably indicating long-
lasting increased calcium extrusion after transient rise in intra-
cellular calcium.
To verify that TRPV1 channels are involved in capsaicin-
induced calcium increase in 3T3-L1-preadipocytes and
capsaicin-dependent prevention of adipogenesis, TRPV1 knock-
down was performed by gene silencing with RNA interference
using specific RNA interference (RNAi).16 Compared with
empty-control-transfected 3T3-L1-preadipocytes the TRPV1 ex-
pression in RNAi-transfected 3T3-L1-preadipocytes was signif-
icantly reduced to 383% (n3; P0.05). The thereby reduced
TRPV1 channel expression caused a significant reduction of
capsaicin-induced calcium increase from 10016% in empty-
control-transfected 3T3-L1-preadipocytes to 163% in TRPV1
RNAi-transfected 3T3-L1-preadipocytes (n10; P0.01;
Figure 1h). Adipogenesis was induced in TRPV1 knock-
down 3T3-L1-preadipocytes and control-transfected 3T3-L1-
preadipocytes by 3-isobutyl-1-methylxanthine, dexametha-
sone, and insulin and adipogenesis was evaluated by oil red
O-staining of lipid droplets (Figure 1i). As expected, in
TRPV1 knockdown 3T3-L1-preadipocytes the administration
of capsaicin did not prevent adipogenesis, whereas in control-
transfected 3T3-L1-preadipocytes the TRPV1 agonist capsa-
icin prevented adipogenesis. These experiments confirmed
the necessity of TRPV1 channel activation in capsaicin-
dependent prevention of adipogenesis.
Now the question arises, whether downregulation of TRPV1
channels is a common finding in several animal models of
obesity as well as in human obesity. We therefore investigated
TRPV1 channel expression using immunoblotting and mRNA
detection in visceral adipose tissue from genetically obese db/db
mice, which have a nonfunctional leptin receptor, and from
obese ob/ob mice, which have a naturally occurring leptin
deletion.23 As shown in Figure 2a through 2d, genetically obese
db/db mice (body weight, 271g; abdominal circumference,
8.10.1 cm; visceral fat, 1.60.1 g) had significantly lower
TRPV1 channel expression (Figure 2b) and TRPV1 mRNA
(Figure 2c; 0.500.01 versus 0.710.05; each n6; P0.01) in
Figure 2. Reduced TRPV1 expression in visceral adipose tissue from obese db/db mice (upper panel), obese ob/ob mice (middle
panel) and obese human male subjects (lower panel). Picture of body shape and abdominal situs showing visceral fat (a and e); expres-
sion of TRPV1 in visceral adipose tissue (b and f); representative agarose gel electrophoresis of PCR products from mRNA of TRPV1
and GAPDH genes in visceral adipose tissue (c and g), M denotes bp marker; and summary data (d and h); each n4. **P0.01
between groups. Lower panels show data from age-matched human male control subjects and obese human male subjects. Waist cir-
cumference (i); each n8. ***P0.001 between groups; expression of TRPV1 in visceral adipose tissue and subcutaneous fat (j); repre-
sentative quantitative real-time RT-PCR from visceral adipose tissue (k) from 1 human male control subject (black line) and from 1
obese human male subject (red line); y-axis denotes fluorescence at 530 nm in arbitrary units, and x-axis denotes number of cycles of
the quantitative real-time RT-PCR; The shift of the red line to the right compared with the black line indicates reduced TRPV1 tran-
scripts in obese subjects; summary data of quantitative real-time RT-PCR are given in (l); n4. *P0.05 between groups. Quantitative
in-cell Western assay of TRPV1 expression in visceral adipose tissue (m), representative capsaicin-induced calcium influx into visceral
adipose tissue from 1 human control subject (open circles) and 1 obese human subject (filled circles) (n); and summary data (o); each
n4; *P0.05).
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visceral adipose tissue compared with their lean littermates
(body weight, 161g; abdominal circumference, 6.10.3 cm;
visceral fat, 0.30.1 g). As shown in Figure 2e through 2h,
leptin-deficient obese ob/ob mice (body weight, 504 g; ab-
dominal circumference, 11.60.1 cm; visceral fat, 5.00.4 g)
had significantly lower TRPV1 channel expression (Figure 2f)
and TRPV1 mRNA (Figure 2g; 0.730.10 versus 1.410.13;
each n6; P0.01) in visceral adipose tissue compared with
lean C57BL/6 counterparts (body weight, 251 g; abdominal
circumference, 7.90.2 cm; visceral fat, 0.60.2 g).
We further investigated TRPV1 channel expression in
adipose tissue from human male subjects. Visceral adipose
tissue and subcutaneous fat was obtained during cholecystec-
tomy. Subjects were classified obese if waist circumference was
more than 90 cm according to the Asian WHO criteria.20,21 Eight
lean male control subjects (age, 431 years; body mass index,
24.41.4 kg/m2, serum triglycerides, 4.60.4 mmol/L) had a
waist circumference of 82.81.5 cm, whereas 8 age-matched
obese male subjects (age, 442 years, body mass index,
26.30.4 kg/m2, serum triglycerides, 4.90.6 mmol/L) had a
significantly higher waist circumference of 92.00.8 cm
(P0.001 for the waist circumference between the groups;
Figure 2i). Western blot shows that obese human male
subjects had significantly lower TRPV1 channel expression
in visceral adipose tissue (0.700.15 versus 4.931.07; each
n8; P0.01) and subcutaneous fat (1.220.08 versus
1.700.13; each n8; P0.01) compared with age-matched
lean human male control subjects (Figure 2j). Using quanti-
tative real-time RT-PCR from visceral adipose tissue (Figure
2k and 2l) we showed that obese human male subjects had
significantly reduced TRPV1 mRNA compared with age-
matched lean human male control subjects (normalized ratio,
0.430.16 versus 1.050.19, n4; P0.05).
Next we evaluated whether reduced TRPV1 expression is
also linked to reduced calcium influx in visceral adipose
tissue from 4 control subjects (body mass index, 23.50.3
kg/m2) and 4 age-matched obese subjects (body mass index,
32.42.0 kg/m2). Normalized TRPV1 protein expression by
quantitative in-cell Western assay in visceral adipose tissue
was significantly lower in obese subjects compared with
control subjects (normalized TRPV1 expression, 1.02007
versus 5.050.49; each n4, P0.05; Figure 2m). The
capsaicin-induced calcium influx was significantly lower in
obese subjects compared with control subjects (0.20.1 versus
1.30.2; each n4; P0.05; Figure 2n and 2o).
These findings indicated that downregulation of TRPV1
channel in visceral adipose tissue is a common finding
for obesity. Hence a putative intervention which activates
TRPV1 channels to prevent obesity should start early during
adipogenesis.
As proof of principle we now evaluated whether continu-
ous activation of TRPV1 channels by capsaicin can prevent
obesity, hypertrophy of adipocytes, and prevent downregula-
tion of TRPV1 channels in male mice assigned to high fat
diet. We first analyzed the biometrical characteristics of mice
on control diet and high fat diet, both in the absence and
presence of TRPV1 channel agonist capsaicin (Figure 3).
After 120 days mice on high fat diet had significantly higher
body weight compared with control mice (441 g versus
291 g; each n10; P0.01). Mice on high fat diet plus
capsaicin remained lean (311 g; n10; P0.01 compared
with mice on high fat diet). Body weight of mice on control
diet plus capsaicin was not significantly different to mice on
control diet (271 g versus 291 g; each n10; pn.s.). As
shown in Figure 3c we observed a decrease in food intake
within the first days after starting capsaicin administration.
However, 10 days after starting capsaicin administration the
food intake was not significantly different between the groups
(food intake per mouse per day in control mice, 4.60.1 g;
mice on high fat diet, 4.80.1 g; control mice with capsaicin,
4.80.1; mice on high fat diet with capsaicin, 4.70.1 g;
pn.s. by ANOVA). These data indicated that long term feeding
with capsaicin did not change food intake. Mice on high fat diet
showed obesity with significantly increased waist circumference
and increased plasma triglyceride levels compared with control
mice or mice on high fat diet plus capsaicin. Mice on high fat
diet had significantly more visceral adipose tissue, subcutaneous
fat and brown fat compared with control mice or mice on high
fat diet plus capsaicin (Figure 3d through 3i). These data
indicated that the administration of the TRPV1 agonist capsaicin
prevented obesity in mice on high fat diet.
Figure 4 shows adipocyte size and TRPV1 channel expres-
sion in adipose tissue in mice. Mice on high fat diet had
significantly increased adipocyte size in visceral adipose
tissue compared with control mice (3708199 m2, n78;
versus 106237 m2, n101 P0.001). Mice on high fat
diet plus capsaicin had small adipocytes size (125564 m2,
n90; P0.001 compared with mice on high fat diet).
Similar findings could be obtained in subcutaneous fat and
brown fat (Figure 4b through 4d). Mice on high fat diet had
significantly reduced TRPV1 channel expression in visceral
adipose tissue compared with control mice (0.440.06 versus
1.000.05; each n10; P0.001). Furthermore, mice on
high fat diet plus capsaicin had significantly increased TRPV1
channel expression in visceral adipose tissue (1.180.08, n10;
P0.001) compared with mice on high fat diet (Figure 4e). The
administration of capsaicin increased TRPV1 channel expres-
sion in visceral adipose tissue by 169%. As shown in Figure 4f
mice on high fat diet had reduced TRPV1 mRNA in visceral
adipose tissue compared with control mice. Furthermore, mice
on high fat diet plus capsaicin had increased TRPV1 mRNA in
visceral adipose tissue compared with mice on high fat diet,
supporting the protein expression data.
As appropriate controls TRPV1 knockout mice were
exposed to high fat diet in the presence and absence of
capsaicin. As could be predicted from the findings presented
above, in TRPV1 knockout mice on high fat diet for 60 days
the body weight was not significantly different in the absence
and presence of the TRPV1 agonist capsaicin (30.30.7 g
versus 29.80.4 g; each n3; pn.s.). In contrast wild-type
mice on high fat diet for 60 days had a body weight of
32.00.4 g, whereas wild-type mice on high fat diet plus
capsaicin a significantly reduced body weight of 27.21.3 g
(each n5; P0.05 compared with mice on high fat diet).
These data strongly support the hypothesis that the preventive
effects of capsaicin are mediated by the TRPV1 channel.
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Discussion
TRPV1 channels have been described in several tissues.24
This study for the first time detected TRPV1 transcripts and
channel protein in 3T3-L1-preadipocytes and adipose tissue
both in mice and humans. A limitation of the present study is
that although we observed reduced TRPV1 expression both
on transcript level and on protein level in two obese animal
models and in obese humans compared with lean counterparts
it is yet unknown whether there is a linear association
between body mass index or waist circumference and TRPV1
expression levels. This would need larger cohort studies
which may be difficult because of the limited availability of
human visceral adipose tissue.
The TRPV1 agonist capsaicin dose-dependently increased
intracellular calcium in 3T3-L1-preadipocytes. After TRPV1
knockdown by gene silencing with RNA interference using
specific RNAi the capsaicin-induced calcium increase was
significantly attenuated in 3T3-L1-preadipocytes. The
capsaicin-induced calcium influx through TRPV1 channels
has already been reported in HEK293 cells transfected with
TRPV1 channels, neurons, and hepatoblastoma cells.6,22,25
Furthermore, capsaicin had several effects on nonneuronal
tissues.26 Capsaicin activates migration of human polymor-
phonuclear cells and elicited a substantial constriction in
isolated arterioles which may be related to capsaicin-induced
transplasmamembrane calcium influx.26,27 As detailed in a
review by Szallasi and Blumberg, capsaicin is a known
specific agonist of TRPV1 channels.26 The potency of
capsaicin-induced calcium influx was 320 nmol/L in neurons,
660 nmol/L in mast cells and 380 nmol/L in glioma cells.26 In
our study the capsaicin-induced calcium influx was dose-
dependent and thus confirmed the functional properties of
TRPV1 channels in preadipocytes. It should be noted that
capsaicin concentrations as low as 10nmol/L showed calcium
influx in preadipocytes. The characteristics of capsaicin-
induced calcium entry through TRPV1 channels was similar
to that reported by Caterina et al6 and Savidge et al22 and
matches the characteristics of the TRPV1 channel.
Previous studies indicated that adipogenesis is regulated by
calcium.10,11 Shi et al reported that elevated calcium markedly
suppressed adipogenesis with a decrease in triglyceride ac-
cumulation and a substantial inhibition in PPAR- expres-
sion.11 In the present study adipogenesis was induced in
3T3-L1-preadipocytes using 3-isobutyl-1-methylxanthine,
dexamethasone, and insulin.12,13 We showed that capsaicin-
induced elevation of cytosolic calcium reduced intracellular
lipid droplets, reduced triglyceride levels, reduced expression
of PPAR- and reduced fatty acid synthase in stimulated
Figure 3. The TRPV1 channel agonist capsaicin prevents obesity in mice on high fat diet. a, Time course of body weight from control
mice (open circles), mice on high fat diet (filled circles), control mice with capsaicin (open squares), and mice on high fat diet with cap-
saicin (filled squares; each n10); Body weight (b), daily food intake per mouse during the first 10 days after the start of capsaicin
administration in control mice (open circles), mice on high fat diet (filled circles), control mice with capsaicin (open squares), and mice
on high fat diet with capsaicin (filled squares; each n10) (c), picture of body shape of mice (d), waist circumference (e), serum triglyc-
erides (f), visceral adipose tissue (g), subcutaneous fat (h), brown fat (i) at the age of 120 days of control mice (n10), mice on high fat
diet (n10), control mice plus capsaicin (n10), and mice on high fat diet plus capsaicin (n10). **P0.01 for the comparison high fat
vs control; P0.01 for the comparison high fat plus capsaicin vs high fat.
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preadipocytes, whereas administration of the TRPV1 antag-
onist capsazepine did not prevent adipogenesis. Furthermore,
after TRPV1 knockdown the administration of capsaicin did
not prevent adipogenesis in TRPV1 knockdown 3T3-L1-
preadipocytes. Hence we confirmed that increased calcium
after administration of capsaicin significantly blocked adipo-
genesis in stimulated 3T3-L1-preadipocytes.11,28,29
As proof of principle the effect of capsaicin on adipogen-
esis and obesity was then investigated in vivo, both in control
mice and in TRPV1 knockout mice. Our long term feeding
experiments showed that the administration of capsaicin
prevented obesity in male wild-type mice assigned to high fat
diet but not in TRPV1 knockout mice assigned to high fat
diet, indicating that TRPV1 is directly involved in adipogen-
esis and obesity in vivo.
Capsaicin has been reported to reduce adiposity in rats and
mice, which was partly explained by its effect on energy and
lipid metabolism via catecholamine secretion from the adre-
nal medulla through sympathetic activation of the central
nervous system. However, these effects on catecholamine
secretion were observed after intravenous administration of
capsaicin in anesthetized rats.30 It is unclear whether these
mechanisms may also explain the long term effects of oral
administration of capsaicin on obesity. Furthermore, sympa-
thetic activity has shown consistent elevation in obesity,
whereas catecholamine levels in obesity have been conflict-
ing, with high, normal, and low levels reported.31
In the present long term feeding study changes of food
intake in the presence of capsaicin have been ruled out by
measurements of food intake. We showed a decrease in food
intake within the first few days after starting the administra-
tion of capsaicin confirming a recent study by Wang et al who
reported reduced short term food intake after TRPV1 activa-
tion of sensory neurons.32 We showed that 10 days after
starting capsaicin administration the food intake was similar
in the presence and absence of capsaicin, which is in accordance
with findings in obese Zucker rats.33 An effect of red pepper
on thermogenesis has been described.4 However, several
evidences indicated that afferent reflexes are mainly respon-
sible for diet-induced thermogenesis.34–36
Using normal diet, Rong et al did not report a significant
difference of feeding behavior, growth rate and body weight
between TRPV1 knockout mice and wild-type mice.37 How-
ever, no long term feeding studies comparing high fat diet
with normal diet have yet been reported in TRPV1 knockout
mice. In the present study we showed for the first time that
capsaicin did not prevent adipogenesis and obesity in TRPV1
knockout mice on high fat diet.
In conclusion we present in vitro and in vivo evidences that
capsaicin-induced calcium influx through TRPV1 channels
prevents adipogenesis, prevents downregulation of TRPV1
expression and finally prevents obesity.
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Materials and Methods 
 
Cell culture and adipocyte differentiation assay 
Murine 3T3-L1 preadipocytes as previously described1-4 were cultured and maintained in 
Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (HyClone) 
containing 100 µg/ml penicillin and 100 µg/ml streptomycin (GIBCO). Cells were plated and 
grown until 2 days post-confluence. Differentiation was then induced (day 0) by changing the 
medium to Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum, 
0.5 mmol/L 3-isobutyl-1-methylxanthine, 1 µmol/L dexamethasone, and 5 µg/mL insulin.3,4 
Differentiation was performed in the absence and presence of 1 µmol/L capsaicin or 1 µmol/L 
capsazepine as indicated. Capsaicin or capsazepine were continuously present during the cell 
culture if no indicated otherwise. Cells were cultured, fixed and stained with the lipophilic 
dye oil red O (Sigma-Aldrich). Red staining shows lipid droplets in the cytoplasm indicating 
adipocyte differentiation.4 Stained cells were either photographed or counterstained with 
Giemsa and visualized by bright field microscopy. The viability of cells after administration 
of capsaicin was checked using the trypan blue exclusion method and showed a cell viability 
more than 95%. The differentiation of preadipocytes was further examined by determination 
of triglyceride levels in cells, and by immunoblottings of the expression of peroxisome 
proliferator-activated receptor-gamma (PPAR-γ), a key transcriptional regulator of 
adipogenesis,5 and the expression of fatty acid synthase, a key enzyme in de novo 
lipogenesis.6 
 
Selective silencing of TRPV1 by RNA interference 
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Selective silencing of TRPV1 by RNA interference using a lentiviral system was performed 
according the reported technique.7 The lentiviral system includes three packaging plasmids 
(pLP1, pLP2, and pLP-VSVG) and one expression plasmid (PLL3.7). In order to select the 
cells infected with lentivirus, we replaced the reporter gene (green fluorescent protein, EGFP) 
of PLL3.7 by the Neo gene (called, PLL3.7-Neo). Small hairpin oligonucleotides DNA were 
synthesized and targeted the following sequences in TRPV1 cDNA, 
(1)GACAGATAGCCTGAAGCAG; and (2) GCGCATCTTCTACTTCAAC. Two 
oligonucleotides DNA were synthesized: 
M547-569: 
P1:5’-TGACAGATAGCCTGAAGCAGTTCAAGAGACTGCTTCAGGCTATCTGTCTTTT
TTC-3’; 
P2:5’-TCGAGAAAAAAGACAGATAGCCTGAAGCAGTCTCTTGAACTGCTTCAGGCT
ATCTGTCA-3’ 
M1294-1316:  
H1:5’-TGCGCATCTTCTACTTCAACTTCAAGAGAGTTGAAGTAGAAGATGCGCTTTT
TTC-3’ 
H2:5’-TCGAGAAAAAAGCGCATCTTCTACTTCAACTCTCTTGAAGTTGAAGTAGAA
GATGCGCA-3’ 
HpaI-XhoI were used to linearize the PLL3.7 expression plasmid. Recombined expression 
plasmids PLL3.7-Neo-(1) and PLL3.7-Neo-(2) were constructed by linking the small hairpin 
DNA-(1) and DNA-(2) with the linear vector. The PLL3.7 plasmid was used as negative 
control. The recombinant plasmids were identified by digestion with XhoI-XbaI and DNA 
sequence analysis. 
Viral production was performed in 293FT cell. 1.5 µg packaging plasmids, 0.5 µg 
recombinant expression plasmids and 6 µL lipofectamine 2000 were added into 500 µL Opti-
MEM (antibiotics free), mixed gently and incubated for 20 minutes at room temperature. 
Then the DNA-lipofectamine complexes and 1 mL of the 293FT cell suspension (a total of 
106 cells) were added to the plate containing 1 mL of Opti-MEM (antibiotics free), and 
incubated overnight at 37°C. Then medium was replaced by Opti-MEM containing 
0.1 mmol/L non-essential amino acids and 1 mmol/L sodium pyruvate. Supernatants were 
collected 72 h after transfection and viral stocks were stored at -80°C. The recombined 
lentivirus named TRPV1-Neo-RNAi(1), TRPV1-Neo-RNAi(2) and TRPV1-Neo-RNAi-
empty were collected 72 hours after transfection. 
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3T3-L1 preadipocytes stably expressing siRNA were generated by transfection with TRPV1-
Neo-RNAi(1), TRPV1-Neo-RNAi(2) and TRPV1-Neo-RNAi-empty. 3T3-L1 preadipocytes 
were cultured in 24-well plates to 50% confluence and 500 µL recombined lentivirus 
(containing 6 µg/mL polybrene) were added for transfection for 24 hours. Then cells were 
gently washed using PBS, fresh Opti-MEM was added, and 3T3-L1 preadipocytes were 
cultured for 2 days. Medium containing 800 µg/mL G418 was added to remove non-
transfected cells and remaining transfected 3T3-L1 preadipocytes were further cultured. PCR 
was used to identify PLL3.7-Neo in transduced 3T3-L1 preadipocytes using the primers 
5’-AGGAAACTCACCCTAACTG-3’ and 5’-GGCTATGAACTAATGACCC-3’ (Sangon 
Biological Engineering). Genomic DNA of transfected 3T3-L1 preadipocytes was extracted 
and used as template. PCR samples (total volume, 30 µL) contained 0.6 µL dNTP, 1.2 µL 
primer, 1 µL extracted DNA and 0.6 µl TaqDNA polymerase. PCR was started with 
denaturation at 95°C for 10 minutes. Then 30 cycles were performed under the following 
conditions: denaturation at 95°C for 30 seconds, annealing at 55°C for 30 seconds, and 
extension at 72°C for 40 seconds. The PCR products were size fractionated on 2% agarose 
gels, and DNA was visualized by SYBR green staining using an imaging analyzer (Gel Doc 
2000, BioRad). The expected size of the PCR product was 275 bp. The expected size of PCR 
products of constructed plasmids was 320 bp because of the inserted oligonucleotides. Both, 
RNAi-transfected and empty-control transfected 3T3-L1-preadipocytes were used for calcium 
measurements and for adipocyte differentiation assay. 
 
Fluorescence measurements 
Cytosolic calcium concentrations were measured in 3T3-L1-preadipocytes, 3T3-L1-
preadipocytes that had been transfected with RNAi against TRPV, and adipocytes. Cells were 
loaded with the fluorescent dye fura2 according to previously published techniques by our 
group.8,9 Cells were grown on square coverslips, washed twice with physiological saline 
solution (PSS, containing in mmol/L, NaCl 135, KCL 5, CaCl2 1, MgCl2 1, D-glucose 5.5, N-
2-hydroxyethyl-piperazine-N'-2-ethanesulfonic acid (HEPES) 10, pH 7.4 and incubated with 
2 µmol/L of the cell-permeant fura2-acetoxymethylester for 60 minutes at 37°C. After loading 
of the cells with fura2, the experiments were continued only when a viability higher than 95% 
was observed using trypan blue exclusion. At the end of the loading period, the coverslips 
were washed twice in PSS and the fluorescence intensity of fura2-loaded cells was measured 
at 37°C using a spectrophotometer equipped with a thermostatically controlled cuvette holder, 
The light source was a 150 Watt xenon lamp with ozone self-dissociation function. The 
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wavelength drive motors and slit control motors were operated using the computer. The 
wavelength accuracy was better than  ±5nm. Output signals from the monitor detector and he 
fluorescence detector (photomultiplier) were processed via the analog-to-digital converter. 
The complete intracellular hydrolysis of fura2-acetoxymethyester to fura2 was judged by the 
changes in the excitation and emission spectra. The fluorescence of fura2 was measured using 
a data-sampling interval of 1 second with alternate excitation wavelengths of 340 nm and 
380 nm (bandwidth, 5nm), and the emission was collected at 510 nm (bandwidth, 5 nm). 
Autofluorescence was measured in similar cells which had not been loaded with fura2-
acetoxymethylester and was less than 5% of the total fluorescence of fura2-loaded cells. After 
subtraction of autofluorescence for each wavelength, the ratio (R) of the measured 
fluorescence values at 340 nm and 380 nm excitation was calculated. The F340/F380 
excitation ratio of resting cells remained constant during the whole experiment, indicating a 
stable resting calcium concentration. Leakage during the measurements was less than 4% of 
the total fluorescence as observed by quenching external fluorescence with 100µmol/L 
MnCl2. Cells were stimulated with 1 µmol/L capsaicin if not indicated otherwise. Calcium 
influx was also determined in suspensions of human visceral adipose tissue after collagenase 
digestion and loading with the fluorescent dye fura2 as described above. 
 
Immunoblotting 
Immunoblottings of transient receptor potential vanilloid type-1 (TRPV1) channel, ß-actin, 
peroxisome proliferator-activated receptor-gamma (PPAR-γ), and fatty acid synthase from 
3T3-L1 preadipocytes or adipose tissue were performed using standard techniques as reported 
by our group previously.8,9 Tissue was homogenized in high-salt extraction buffer containing 
50 mmol/L Tris, 1 mL NP40, 1 mL TritionX-100, 0.1 g sodium dodecyl sulfate, 150 mmol 
NaCl, 2 mmol/L ethylenediaminetetraacetic acid, 1 mmol ethylene glycol-bis(2-
aminoethylether)-N,N',N'-tetraacetic acid. Tissue was transferred to Eppendorf tubes, and 
homogenized by sonication for 5 seconds. The protein supernatant was separated by 
centrifugation, and protein concentrations were determined with Bio-Rad protein assay 
reagent (Bio-Rad, Hercules CA). Proteins were separated by using 10% SDS-polyacrylamide 
gel, transferred to polyvinylidene difluoride membranes at 90 mA overnight, and 
immunodetected with the ECF kit (Amersham). Rabbit anti-TRPV1 antibodies were 
purchased from alomone labs (Jerusalem, Israel) and other antibodies were purchased from 
Santa Cruz Biotechnology (Santa Cruz, CA). After incubation with the secondary antibodies 
for 1 hour, the proteins were detected by enhanced chemiluminescence and quantified using a 
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Gel Doc 2000 Imager (Bio-Rad). Each sample was processed at least 3 times. In-cell Western 
assay of TRPV1 channels human visceral adipose tissue was performed using the Odyssey 
infrared imaging system (Licor biosciences) as described by our group.9 Primary rabbit anti-
human TRPV1-antibodies were obtained from Alomone labs (Jerusalem, Israel) and 
secondary IRDye800CW-infrared fluorescent dye-conjugated goat anti-rabbit antibodies were 
obtained from Biomol (Hamburg, Germany). Imaging was performed at 810 nm emission 
with an excitation wavelength of 780 nm. 
 
Immunohistochemistry 
For immunohistochemistry isolated 3T3-L1 preadipocytes or adipocytes from visceral adipose 
tissue were fixed on glass slides for 10 minutes in 70 % ethanol at room temperature, washed 
twice in phosphate buffered saline, and fixed cells were dried on air, blocked with 1% bovine 
serum albumin for 1 h and then incubated with the primary antibody, TRPV1 (1:200), 
overnight at 4°C. Cells were then washed three times with phosphate buffered saline and then 
incubated for 30 minutes at 37°C with the fluorescent-dye labeled secondary antibody 
(IRDye800CW-infrared fluorescent dye-conjugated sheep anti-rabbit antibodies, 1:200; Santa 
Cruz Biotech, Inc. CA, USA; 1:1000) and analyzed with a Motic microscope. Control 
experiments were performed in the absence of primary antibody. Non-specific fluorescence in 
the absence of primary antibody was less than 3% of the fluorescence in the presence of the 
primary antibody. 
 
Semiquantitative conventional polymerase chain reaction (PCR) 
Expression of TRPV1 mRNA and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 
mRNA as internal control was measured in 3T3-L1 preadipocytes or adipose tissue after 
extraction of RNA by tripure isolation reagents. RNA was used to synthesize first-strand 
cDNA using the Reverse Transcription System (Promega, Madison WI), 4 µg of purified 
mRNA was reverse-transcribed with a RT mixture consisting of oligo dT (12 to 18) and 5 U 
AMV reverse transcriptase at 42°C for 60 minutes, followed by heating to 99°C for 5 
minutes. The single stranded cDNA was amplified by PCR using taq DNA polymerase 
(Sangon Biological Engineering, Shanghai, China). PCR reaction was performed using 3 µL 
of cDNA, 3 µL of PCR buffer 10x, 10mmol/l dNTP, 0.6 µL primers, and 2.5 IU taq DNA 
polymerase in a total reaction volume of 30µL. The sense and antisense primers for coding 
regions of TRPV1 or GAPDH genes were the following: TRPV1 (Reference Sequence 
(RefSeq) database accession number: NM_001001445), forward, 5'-
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TGCCCTATCATCACCGTCAG-3'; reverse, 5'-GTGTTGCCCACCGAATCCC-3'; expected 
size, 644bp; GAPDH (RefSeq BC095932); forward, 5'-ACCTCAACTACATGGTCTAC-3′ 
reverse, 5'-TTGTCATTGAGAGCAATGCC-3′; expected size, 802bp. The reaction was 
initiated at 94°C for 10 minutes and followed by 35 cycles of denaturation at 94°C for 90 
seconds, annealing at 58°C for 60 seconds, and extension at 72°C for 60 seconds. The 
reaction was achieved with a final extension at 72°C for 7 minutes. Each sample was run in 
parallel with the housekeeping gene. Control experiments in which reverse transcriptase was 
omitted were performed in order to exclude the possibility that the signal detected could come 
from the genomic DNA. 10 µL of the PCR products were size fractionated on agarose gel 
(1.5%) and quantified using a Gel Doc 2000 Imager (Bio-Rad). 
 
Quantitative real-time PCR 
In visceral adipose tissue and in subcutaneous fat from humans the expression of TRPV1 
mRNA and GAPDH mRNA as internal control was quantified using quantitative real-time 
PCR (LightCycler, Roche Diagnostics, Mannheim, Germany). RNA was extracted and first-
strand cDNA was synthesized as described above. Gene specific PCR primers for human 
TRPV1 and the housekeeping gene GAPDH were designed using Lasergene7 (DNA-Star, 
Madison, Wisconsin). To avoid the amplification of genomic DNA, primers were chosen in 
different exons. The primers for real-time PCR were the following: human TRPV1 (RefSeq 
NM_080704); forward, 5'-CTCCCTGCCGTCTGAGTCCA-3'; reverse, 5'-
AGTGTCTGCCTGAAACTCTGCTT-3'; expected size, 548bp. human GAPDH (RefSeq 
NM_002046); forward, 5'-AACTGCTTAGCACCCCTGGC-3′; reverse, 5'-
ATGACCTTGCCCACAGCCTT-3′; expected size, 200bp. The TRPV1 and the GAPDH 
housekeeping gene were amplified in parallel. Quantitative real-time PCR was performed 
using 2 µL of single stranded cDNA which was added to a final volume of 20 µL, which 
contained 4 µL of LightCycler-Fast Start DNA SYBR Green I mix (Roche Diagnostics), and 
500 nmol/L of each primer. The reaction was initiated at 95°C for 10 minutes, and followed 
by 40 cycles of denaturation at 95°C for 10 seconds, annealing for 10 seconds at 58°C for 
TRPV1 or at 54°C for GAPDH, and extension at 72°C for 15 seconds. Fluorescent data were 
acquired at the end of each extension phase. After amplification, a melting curve analysis 
from 65°C to 95°C with a heating rate of 0.1°C per second with a continuous fluorescence 
acquisition was made. Data were recorded on an LightCycler 2.0 Instrument (Roche 
Diagnostics) and cycle thresholds (crossing points, Cp) values for each reaction were 
determined using LightCycler Software Version 4.0 (Roche Diagnostics). Calibration curves 
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were generated from serial dilutions of cDNAs for both TRPV1 gene and housekeeping gene 
GAPDH, respectively. Relations (plots of Cp versus the log of dilution) were linear and 
showed a correlation coefficient of 0.99. The efficiency was 2.091 for TRPV1 and the 
efficiency was 1.986 for GAPDH. Each cDNA of four independent experiments was 
amplified in duplicate and Cp values were averaged from each duplicate. To account for 
differences in RNA loading TRPV1 was expressed relative to GAPDH housekeeping gene. 
Normalized ratios of TRPV1 expression were calculated according to the manufacturers 
recommendations including efficiency correction and calibrator normalization.  
 
Animals 
All mice (db/db mice, ob/ob mice, C57BL/6 wild-type mice, and TRPV1 knock-out mice) 
were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA). For feeding 
experiments mice were obtained from an in-house breeding colony based on a C57BL/6 wild-
type genetic background (The Jackson Laboratory). Male mice were randomized into four 
groups; one group received standard laboratory chow, one group received high-fat diet, one 
group received standard laboratory chow plus 0.01% capsaicin, one group received high-fat 
diet plus 0.01% capsaicin. Hence, the approximate capsaicin intake was 1.64 µmol/day per 
mouse. Assuming a bioavailability of 1% the capsaicin intake produces a plasma 
concentration of more than 10 µmol/L in mice. The high-fat diet supplied 49% of the calories 
as fat and 30% of the calories as carbohydrate. The standard laboratory chow diet provided 
10% of the calories as fat and 68% as carbohydrate. Mice were housed in a pathogen-free 
animal facility and allowed water and food ad libitum. Food intake was controlled every day. 
All animals were subject to controlled temperature (22 ± 1 °C) and lighting (lights on 06.00 to 
18.00). Serum triglycerides were analyzed using routine techniques. Animal treatment and 
care was provided in accordance with institutional guidelines. All of the experimental 
procedures were performed in accordance with protocols approved by the Institutional Animal 
Care and Research Advisory Committee. 
 
Determination of adipocyte size 
Adipocyte size was determined in tissue according to established techniques.10 Tissue was 
fixed in 10% formaldehyde/phosphate buffered saline and embedded in paraffin. Sections 
were stained with hematoxylin and eosin and studied under x400 magnification compare 
adipocytes size using a light microscope (Motic Digital Microscope B5 Professional, Xiemen, 
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China) and photomicrographs were obtained. The adipocytes diameter and area were analyzed 
using IPLab software (Scanalytics Inc, Fairfax, VA). 
 
Patients 
Subjects were classified obese if waist circumference was more than 90 cm according to the 
Asian criteria of the WHO Regional Office for the Western Pacific / International Association 
for the Study of Obesity/International Obesity Task Force.11,12 Age, body mass index, waist 
circumference, and triglycerides were obtained. TRPV1 channel expression was evaluated in 
visceral adipose tissue and subcutaneous fat which was obtained during regular scheduled 
cholecystectomy. Cholecystektomy had to be performed because of symptomatic gallstones. 
Visceral fat tissue was also obtained from subjects scheduled for an urological procedure. The 
protocol was approved by the local Ethics Committee. All patients gave written informed 
consent.  
 
Statistics 
All values reported are mean ± SEM. Comparisons between groups were analyzed using 
Student t-test or one-way ANOVA with Bonferroni's multiple comparison post hoc test as 
appropriate (GraphPad Prism; LaJolla CA). Two-sided p values below 0.05 were considered 
to indicate statistical significance. 
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